SynthesisBMC rheumatology2025

Efficacy and safety of non-conventional synthetic disease-modifying antirheumatic drugs in early active rheumatoid arthritis: a network meta-analysis.

Haimei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.